Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

ST801a

Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases/80 cores, replacing ST801
Unstained: $225.00 Add to Cart
H&E (ST801as*): $225.00 Add to Cart

Microarray Panel:Gastric adenocarcinoma with matched adjacent normal tissue microarry, containing 36 cases of stomach adenocarcinoma, 2 stomach mucinous adenocarcinoma, 1 each of stomach signet ring cell carcinoma and carcinoid, duplicate cores per case
Cores:80
Cases:40
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
B Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
C Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
D Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
E Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
F Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
G Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto  
H Sto Sto Sto Sto Sto Sto Sto Sto Sto Sto Marked point
Legend: Sto - Stomach

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage IB), - Malignant tumor (stage II), - Malignant tumor (stage IIIA), - Malignant tumor (stage IIIB), - Malignant tumor (stage IIIa), - Malignant tumor (stage Ib), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 78 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A2 2 F 78 Stomach Cancer adjacent normal stomach tissue – – – NAT
A3 3 M 67 Stomach Adenocarcinoma (sparse) 1 IB T2N0M1 Malignant
A4 4 M 67 Stomach Cancer adjacent normal stomach tissue – – – NAT
A5 5 F 59 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A6 6 F 59 Stomach Cancer adjacent normal stomach tissue – – – NAT
A7 7 M 50 Stomach Mucinous adenocarcinoma 1 II T3N0M0 Malignant
A8 8 M 50 Stomach Cancer adjacent normal stomach tissue with chronic inflammation – – – NAT
A9 9 F 51 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A10 10 F 51 Stomach Cancer adjacent normal stomach tissue – – – NAT
B1 11 F 68 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
B2 12 F 68 Stomach Moderate atrophic gastritis – – – NAT
B3 13 M 48 Stomach Adenocarcinoma 1 Ib T2N0M0 Malignant
B4 14 M 48 Stomach Cancer adjacent normal stomach tissue – – – NAT
B5 15 M 56 Stomach Adenocarcinoma 2 IB T2bN0M0 Malignant
B6 16 M 56 Stomach Cancer adjacent normal stomach tissue – – – NAT
B7 17 M 57 Stomach Adenocarcinoma 2 IB T2bN0M0 Malignant
B8 18 M 57 Stomach Cancer adjacent normal stomach tissue – – – NAT
B9 19 M 74 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B10 20 M 74 Stomach Cancer adjacent normal stomach tissue – – – NAT
C1 21 M 52 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C2 22 M 52 Stomach Cancer adjacent normal stomach tissue – – – NAT
C3 23 M 68 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C4 24 M 68 Stomach Cancer adjacent normal stomach tissue – – – NAT
C5 25 M 51 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C6 26 M 51 Stomach Cancer adjacent normal stomach tissue – – – NAT
C7 27 F 55 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C8 28 F 55 Stomach Cancer adjacent normal stomach tissue – – – NAT
C9 29 M 53 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
C10 30 M 53 Stomach Cancer adjacent normal stomach tissue – – – NAT
D1 31 M 54 Stomach Adenocarcinoma 2 Ib T2N0M0 Malignant
D2 32 M 54 Stomach Cancer adjacent normal stomach tissue – – – NAT
D3 33 M 69 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
D4 34 M 69 Stomach Cancer adjacent normal stomach tissue – – – NAT
D5 35 M 72 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D6 36 M 72 Stomach Cancer adjacent normal stomach tissue – – – NAT
D7 37 M 56 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D8 38 M 56 Stomach Cancer adjacent normal stomach tissue – – – NAT
D9 39 F 53 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D10 40 F 53 Stomach Cancer adjacent normal stomach tissue – – – NAT
E1 41 M 61 Stomach Adenocarcinoma 2 IIIA T3N1M0 Malignant
E2 42 M 61 Stomach Cancer adjacent normal stomach tissue with chronic inflammation – – – NAT
E3 43 M 49 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
E4 44 M 49 Stomach Cancer adjacent normal stomach tissue – – – NAT
E5 45 M 53 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E6 46 M 53 Stomach Cancer adjacent normal stomach tissue – – – NAT
E7 47 M 54 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E8 48 M 54 Stomach Cancer adjacent normal stomach tissue – – – NAT
E9 49 M 50 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E10 50 M 50 Stomach Moderate atrophic gastritis with intestinal metaplasia – – – NAT
F1 51 F 63 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
F2 52 F 63 Stomach Cancer adjacent normal stomach tissue – – – NAT
F3 53 F 68 Stomach Adenocarcinoma 3 I T2N0M0 Malignant
F4 54 F 68 Stomach Cancer adjacent normal stomach tissue – – – NAT
F5 55 M 71 Stomach Adenocarcinoma 3 IIIA T3N1M0 Malignant
F6 56 M 71 Stomach Cancer adjacent normal stomach tissue – – – NAT
F7 57 M 61 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
F8 58 M 61 Stomach Cancer adjacent normal stomach tissue – – – NAT
F9 59 M 47 Stomach Adenocarcinoma (sparse) 3 II T2N1M0 Malignant
F10 60 M 47 Stomach Cancer adjacent normal stomach tissue – – – NAT
G1 61 M 58 Stomach Mucinous adenocarcinoma 3 II T3N0M1 Malignant
G2 62 M 58 Stomach Cancer adjacent normal stomach tissue – – – NAT
G3 63 F 63 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
G4 64 F 63 Stomach Cancer adjacent normal stomach tissue – – – NAT
G5 65 M 66 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
G6 66 M 66 Stomach Cancer adjacent normal stomach tissue – – – NAT
G7 67 M 52 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
G8 68 M 52 Stomach Cancer adjacent normal stomach tissue (sparse) – – – NAT
G9 69 F 54 Stomach Adenocarcinoma 3 IIIB T4N1M0 Malignant
G10 70 F 54 Stomach Cancer adjacent normal stomach tissue – – – NAT
H1 71 F 51 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
H2 72 F 51 Stomach Cancer adjacent normal stomach tissue – – – NAT
H3 73 M 64 Stomach Signet-ring cell carcinoma – II T3N0M0 Malignant
H4 74 M 64 Stomach Cancer adjacent normal stomach tissue – – – NAT
H5 75 M 73 Stomach Adenocarcinoma 3 Ib T2N0M0 Malignant
H6 76 M 73 Stomach Cancer adjacent normal stomach tissue – – – NAT
H7 77 M 62 Stomach Carcinoid – IIIa T3N1M0 Malignant
H8 78 M 62 Stomach Cancer adjacent normal stomach tissue – – – NAT
H9 79 M 50 Stomach Adenocarcinoma (smooth muscle tissue) – IIIa T4N0M0 Malignant
H10 80 M 50 Stomach Cancer adjacent normal stomach tissue – – – NAT
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal